Ophthalmology · Sellersville, PA
NPI
1457771537
Since 2014
Specialty
Ophthalmology
Code 207W00000X
Group practices
2
Medicare group memberships
Hospitals
1
Hospital affiliations
711 Lawn Ave Ste 3
Sellersville, PA, 18960
Phone (215) 257-8053
Groups this clinician bills Medicare through
Medicare paid, 2024
$324K
2,462 services
Medicare patients, 2024
789
Average age 75
Drug cost, 2024
$124K
1,383 prescriptions
Company payments, 2025
$511
From 9 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Syed A Karim was code 99214 (office e&m - established), 844 times for 558 patients. In total Syed A Karim billed 2,462 services in 53 codes, and Medicare paid $324K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 844 | 558 | $94.93 | $80K |
| 92136 Ultrasound - Nonspecific | Office | 361 | 220 | $30.35 | $11K |
| 66984 Cataract Surgery | Facility | 325 | 188 | $430.09 | $140K |
| 99213 Office E&M - Established | Office | 179 | 161 | $59.15 | $11K |
| 92133 Computerized Ophthalmic Imaging | Office | 112 | 110 | $25.14 | $2,816 |
| 66821 Cataract Surgery | Office | 92 | 70 | $262.58 | $24K |
| 92083 Vision, Hearing, and Speech Services | Office | 84 | 81 | $47.05 | $3,952 |
| 99204 Office E&M - New | Office | 80 | 80 | $111.74 | $8,939 |
| 92134 Computerized Ophthalmic Imaging | Office | 61 | 54 | $28.54 | $1,741 |
| 92014 Ophthalmological E&M | Office | 38 | 38 | $69.46 | $2,640 |
| 99203 Office E&M - New | Office | 31 | 31 | $48.97 | $1,518 |
| 92025 Test - Miscellaneous | Office | 23 | 20 | $24.08 | $554 |
| 92286 Standard X-ray | Office | 18 | 17 | $27.63 | $497 |
| 11900 Skin | Office | 12 | 11 | $47.22 | $567 |
By year: 2022 $288K for 2,323 services; 2023 $302K for 2,296 services; 2024 $324K for 2,462 services.
Medicare prescription drug claims, 2024
In 2024, the drug Syed A Karim prescribed most often to Medicare patients was Prednisolone Acetate, with 295 prescriptions and refills. In total Syed A Karim wrote 1,383 Medicare prescriptions that cost $124K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Prednisolone Acetate Generic | 295 | 393 | 200 | $9,074 |
| Latanoprost Generic | 283 | 569 | 79 | $3,008 |
| Dorzolamide-Timolol Dorzolamide Hcl/Timolol Maleat | 98 | 216 | 31 | $1,522 |
| Brimonidine Tartrate Generic | 89 | 145 | 24 | $675 |
| Erythromycin Erythromycin Base | 85 | 96 | 54 | $957 |
| Timolol Maleate Generic | 83 | 177 | 29 | $761 |
| Ofloxacin Generic | 72 | 78 | 63 | $738 |
| Dorzolamide Hcl Generic | 47 | 108 | Under 11 | $893 |
| Lumigan Bimatoprost | 45 | 71 | Under 11 | $17K |
| Cyclosporine Generic | 38 | 94 | 19 | $27K |
| Loteprednol Etabonate Generic | 29 | 47 | 13 | $3,742 |
| Polymyxin B Sul-Trimethoprim Polymyxin B Sulf/Trimethoprim | 28 | 41 | 25 | $214 |
| Acyclovir Generic | 24 | 32 | Under 11 | $572 |
| Restasis Cyclosporine | 21 | 43 | 13 | $26K |
| Difluprednate Generic | 21 | 22 | Under 11 | $2,097 |
Brand drugs: 504 claims; generic drugs: 879 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Syed A Karim $511 ($511 in general payments such as food, travel and fees) from 9 companies. The largest payer was Alcon Vision LLC with $188.
| Company | Payments | Amount |
|---|---|---|
| Alcon Vision LLC ALC | 3 | $188 |
| Johnson & Johnson Surgical Vision, Inc. JNJ | 2 | $76.66 |
| Bausch & Lomb Americas Inc. BLCO | 2 | $43.58 |
| Tarsus Pharmaceuticals, Inc. TARS | 1 | $37.34 |
| Sun Pharmaceutical Industries Inc. SUNPHARMA.NS | 2 | $35.07 |
| New World Medical,Inc. | 2 | $34.38 |
| Amgen Inc. AMGN | 2 | $34.27 |
| Dompe US, Inc. | 1 | $33.85 |
| Harrow Eye, LLC | 1 | $27.24 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.